Logo image of AKH.OL

AKER HORIZONS ASA (AKH.OL) Stock Fundamental Analysis

OSL:AKH - NO0010921232 - Common Stock

0.515 NOK
-1.55 (-75.06%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, AKH scores 2 out of 10 in our fundamental rating. AKH was compared to 41 industry peers in the Commercial Services & Supplies industry. The financial health of AKH is average, but there are quite some concerns on its profitability. AKH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AKH has reported negative net income.
In the past year AKH had a positive cash flow from operations.
AKH had negative earnings in each of the past 5 years.
AKH had a negative operating cash flow in each of the past 5 years.
AKH.OL Yearly Net Income VS EBIT VS OCF VS FCFAKH.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2B -4B -6B

1.2 Ratios

Looking at the Return On Assets, with a value of -18.60%, AKH is doing worse than 85.71% of the companies in the same industry.
With a Return On Equity value of -510.10%, AKH is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -18.6%
ROE -510.1%
ROIC N/A
ROA(3y)-8.17%
ROA(5y)-9.47%
ROE(3y)-81.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AKH.OL Yearly ROA, ROE, ROICAKH.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 50.66%, AKH is in line with its industry, outperforming 57.14% of the companies in the same industry.
AKH's Gross Margin has improved in the last couple of years.
AKH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y151.02%
GM growth 5YN/A
AKH.OL Yearly Profit, Operating, Gross MarginsAKH.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

5

2. Health

2.1 Basic Checks

AKH does not have a ROIC to compare to the WACC, probably because it is not profitable.
AKH has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for AKH is higher compared to a year ago.
AKH.OL Yearly Shares OutstandingAKH.OL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 200M 400M 600M
AKH.OL Yearly Total Debt VS Total AssetsAKH.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of -0.34, we must say that AKH is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.34, AKH is doing worse than 73.81% of the companies in the same industry.
There is no outstanding debt for AKH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.34
ROIC/WACCN/A
WACC1.74%
AKH.OL Yearly LT Debt VS Equity VS FCFAKH.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5B -5B 10B 15B

2.3 Liquidity

AKH has a Current Ratio of 1.10. This is a normal value and indicates that AKH is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.10, AKH perfoms like the industry average, outperforming 40.48% of the companies in the same industry.
AKH has a Quick Ratio of 1.10. This is a normal value and indicates that AKH is financially healthy and should not expect problems in meeting its short term obligations.
AKH has a Quick ratio of 1.10. This is comparable to the rest of the industry: AKH outperforms 59.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
AKH.OL Yearly Current Assets VS Current LiabilitesAKH.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 92.91% over the past year.
AKH shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.47%.
Measured over the past years, AKH shows a very strong growth in Revenue. The Revenue has been growing by 37.26% on average per year.
EPS 1Y (TTM)92.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-207.65%
Revenue 1Y (TTM)-30.47%
Revenue growth 3Y37.26%
Revenue growth 5YN/A
Sales Q2Q%-99.37%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AKH.OL Yearly Revenue VS EstimatesAKH.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AKH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AKH.OL Price Earnings VS Forward Price EarningsAKH.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AKH.OL Per share dataAKH.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AKH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AKER HORIZONS ASA

OSL:AKH (9/5/2025, 7:00:00 PM)

0.515

-1.55 (-75.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)07-15 2025-07-15
Earnings (Next)10-30 2025-10-30
Inst Owners2.87%
Inst Owner ChangeN/A
Ins Owners1.11%
Ins Owner ChangeN/A
Market Cap355.53M
Analysts47.5
Price Target10.61 (1960.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.89%
PT rev (3m)-1.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF 1.96
P/B 0.44
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-5.91
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.05
FCFYN/A
OCF(TTM)0.26
OCFY50.91%
SpS3.74
BVpS1.16
TBVpS1.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.6%
ROE -510.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.66%
FCFM N/A
ROA(3y)-8.17%
ROA(5y)-9.47%
ROE(3y)-81.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y151.02%
GM growth 5YN/A
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.36%
Cap/Sales 34.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z -0.34
F-Score5
WACC1.74%
ROIC/WACCN/A
Cap/Depr(3y)37.82%
Cap/Depr(5y)720.29%
Cap/Sales(3y)62.82%
Cap/Sales(5y)111.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-207.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.47%
Revenue growth 3Y37.26%
Revenue growth 5YN/A
Sales Q2Q%-99.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y60.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y81.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.18%
OCF growth 3YN/A
OCF growth 5YN/A